UNSPSC 51401512: Menitrazepam

This classification denotes a benzodiazepine with the molecular formula C16H17N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1243654WZK, chemically known as 2h-1,4-benzodiazepin-2-one, 5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-7-nitro- but generally known as menitrazepam, which bears US NIH Compound Identifier 189875. European Medicines Agency schedules Menitrazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08740MIG.

UNSPSC 51401512 Menitrazepam, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS for naloxone and safe drug deactivation systems—does not represent menitrazepam procurement; instead, it reflects a county health department's sourcing of naloxone (a different pharmaceutical entirely) and ancillary harm-reduction equipment. The mismatch suggests either a coding error in the source record or that menitrazepam, a restricted benzodiazepine rarely procured by state and local governments outside specialized law-enforcement or forensic contexts, does not generate routine solicitations under this code in the public marketplace.

The single opportunity on record—Seminole County's IFB posted June 30, 2026, due July 26, 2023—was a straightforward competitive bid for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county required electronic submission through its e-Procurement Portal, E-Verify compliance, drug-free workplace certification, workers' compensation and general liability insurance, and accepted fixed-fee pricing. The contract included a two-year base term with one-year renewal option and a three-month probationary termination clause. No explicit set-asides were designated. Given the mismatch between the code's nominal pharmaceutical scope and the actual naloxone procurement, this code warrants close review before pursuit; state and local governments' actual buying patterns under UNSPSC 51401512 remain unclear from available recent activity.